nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxorubicin—thyroid cancer—hypothyroidism	0.699	1	CtDrD
Doxorubicin—ABCB1—Levothyroxine—hypothyroidism	0.0146	0.28	CbGbCtD
Doxorubicin—ABCB1—Liothyronine—hypothyroidism	0.0146	0.28	CbGbCtD
Doxorubicin—ABCB1—Liotrix—hypothyroidism	0.0143	0.273	CbGbCtD
Doxorubicin—CYP3A4—Levothyroxine—hypothyroidism	0.00878	0.168	CbGbCtD
Doxorubicin—Faecaloma—Liotrix—hypothyroidism	0.00239	0.0274	CcSEcCtD
Doxorubicin—Faecalith—Liotrix—hypothyroidism	0.00239	0.0274	CcSEcCtD
Doxorubicin—Warmth—Liotrix—hypothyroidism	0.00215	0.0246	CcSEcCtD
Doxorubicin—Hyperphosphataemia—Liotrix—hypothyroidism	0.002	0.0229	CcSEcCtD
Doxorubicin—Phlebitis—Liothyronine—hypothyroidism	0.0016	0.0183	CcSEcCtD
Doxorubicin—Cardiac failure congestive—Liothyronine—hypothyroidism	0.00152	0.0174	CcSEcCtD
Doxorubicin—Hypernatraemia—Liotrix—hypothyroidism	0.0013	0.0149	CcSEcCtD
Doxorubicin—Venous thrombosis—Liotrix—hypothyroidism	0.00127	0.0145	CcSEcCtD
Doxorubicin—Angina pectoris—Liothyronine—hypothyroidism	0.00116	0.0133	CcSEcCtD
Doxorubicin—Feeling hot—Liotrix—hypothyroidism	0.000871	0.00999	CcSEcCtD
Doxorubicin—Necrosis—Liotrix—hypothyroidism	0.000871	0.00999	CcSEcCtD
Doxorubicin—Abscess—Liotrix—hypothyroidism	0.000864	0.00991	CcSEcCtD
Doxorubicin—Coma—Dextrothyroxine—hypothyroidism	0.00085	0.00974	CcSEcCtD
Doxorubicin—Coma—Levothyroxine—hypothyroidism	0.00085	0.00974	CcSEcCtD
Doxorubicin—Arrhythmia—Liothyronine—hypothyroidism	0.000849	0.00973	CcSEcCtD
Doxorubicin—ABCB8—adrenal gland—hypothyroidism	0.000797	0.00804	CbGeAlD
Doxorubicin—ABCB8—blood—hypothyroidism	0.000797	0.00804	CbGeAlD
Doxorubicin—AKR1A1—heart—hypothyroidism	0.000794	0.00801	CbGeAlD
Doxorubicin—Extravasation—Liotrix—hypothyroidism	0.000784	0.00898	CcSEcCtD
Doxorubicin—ABCB8—thyroid gland—hypothyroidism	0.000769	0.00776	CbGeAlD
Doxorubicin—CBR3—adrenal gland—hypothyroidism	0.000767	0.00774	CbGeAlD
Doxorubicin—CBR3—blood—hypothyroidism	0.000767	0.00774	CbGeAlD
Doxorubicin—Cellulitis—Liotrix—hypothyroidism	0.000752	0.00862	CcSEcCtD
Doxorubicin—AKR1A1—cardiovascular system—hypothyroidism	0.000749	0.00756	CbGeAlD
Doxorubicin—Hypocalcaemia—Liotrix—hypothyroidism	0.000747	0.00856	CcSEcCtD
Doxorubicin—Cardiac failure congestive—Levothyroxine—hypothyroidism	0.000744	0.00853	CcSEcCtD
Doxorubicin—Cardiac failure congestive—Dextrothyroxine—hypothyroidism	0.000744	0.00853	CcSEcCtD
Doxorubicin—ABCB8—female gonad—hypothyroidism	0.000743	0.0075	CbGeAlD
Doxorubicin—Oliguria—Liotrix—hypothyroidism	0.000742	0.00851	CcSEcCtD
Doxorubicin—CBR3—thyroid gland—hypothyroidism	0.000741	0.00747	CbGeAlD
Doxorubicin—Ulcer—Liotrix—hypothyroidism	0.000723	0.00829	CcSEcCtD
Doxorubicin—NDUFS7—heart—hypothyroidism	0.000722	0.00728	CbGeAlD
Doxorubicin—Creatinine increased—Liotrix—hypothyroidism	0.000718	0.00823	CcSEcCtD
Doxorubicin—Increased appetite—Dextrothyroxine—hypothyroidism	0.000718	0.00823	CcSEcCtD
Doxorubicin—Increased appetite—Levothyroxine—hypothyroidism	0.000718	0.00823	CcSEcCtD
Doxorubicin—CBR3—female gonad—hypothyroidism	0.000716	0.00722	CbGeAlD
Doxorubicin—Hypertension—Liothyronine—hypothyroidism	0.000715	0.00819	CcSEcCtD
Doxorubicin—Hypoglycaemia—Dextrothyroxine—hypothyroidism	0.000692	0.00793	CcSEcCtD
Doxorubicin—Cardiac failure—Levothyroxine—hypothyroidism	0.000692	0.00793	CcSEcCtD
Doxorubicin—Hypoglycaemia—Levothyroxine—hypothyroidism	0.000692	0.00793	CcSEcCtD
Doxorubicin—Cardiac failure—Dextrothyroxine—hypothyroidism	0.000692	0.00793	CcSEcCtD
Doxorubicin—NDUFS7—cardiovascular system—hypothyroidism	0.000681	0.00687	CbGeAlD
Doxorubicin—AKR1A1—gonad—hypothyroidism	0.00068	0.00686	CbGeAlD
Doxorubicin—AURKA—heart—hypothyroidism	0.000671	0.00677	CbGeAlD
Doxorubicin—Affect lability—Dextrothyroxine—hypothyroidism	0.000664	0.00761	CcSEcCtD
Doxorubicin—Affect lability—Levothyroxine—hypothyroidism	0.000664	0.00761	CcSEcCtD
Doxorubicin—AKR1A1—pituitary gland—hypothyroidism	0.000663	0.00669	CbGeAlD
Doxorubicin—ABCB8—testis—hypothyroidism	0.000659	0.00665	CbGeAlD
Doxorubicin—Tachycardia—Liothyronine—hypothyroidism	0.000659	0.00756	CcSEcCtD
Doxorubicin—Fluid retention—Liotrix—hypothyroidism	0.000649	0.00744	CcSEcCtD
Doxorubicin—Blood urea increased—Liotrix—hypothyroidism	0.000646	0.0074	CcSEcCtD
Doxorubicin—Cardiac arrest—Levothyroxine—hypothyroidism	0.000642	0.00736	CcSEcCtD
Doxorubicin—Cardiac arrest—Dextrothyroxine—hypothyroidism	0.000642	0.00736	CcSEcCtD
Doxorubicin—Mood swings—Dextrothyroxine—hypothyroidism	0.000639	0.00733	CcSEcCtD
Doxorubicin—Mood swings—Levothyroxine—hypothyroidism	0.000639	0.00733	CcSEcCtD
Doxorubicin—CBR3—testis—hypothyroidism	0.000635	0.0064	CbGeAlD
Doxorubicin—Hypotension—Liothyronine—hypothyroidism	0.000631	0.00723	CcSEcCtD
Doxorubicin—Dehydration—Levothyroxine—hypothyroidism	0.000628	0.00719	CcSEcCtD
Doxorubicin—Dehydration—Dextrothyroxine—hypothyroidism	0.000628	0.00719	CcSEcCtD
Doxorubicin—Coma—Liotrix—hypothyroidism	0.000625	0.00716	CcSEcCtD
Doxorubicin—ABCB8—liver—hypothyroidism	0.000623	0.00629	CbGeAlD
Doxorubicin—NDUFS2—adrenal cortex—hypothyroidism	0.000618	0.00624	CbGeAlD
Doxorubicin—NDUFS3—adrenal cortex—hypothyroidism	0.000611	0.00616	CbGeAlD
Doxorubicin—ABCB8—cerebellum—hypothyroidism	0.000609	0.00614	CbGeAlD
Doxorubicin—NOS1—heart—hypothyroidism	0.000602	0.00607	CbGeAlD
Doxorubicin—NDUFS2—heart—hypothyroidism	0.000598	0.00603	CbGeAlD
Doxorubicin—Muscular weakness—Levothyroxine—hypothyroidism	0.000595	0.00682	CcSEcCtD
Doxorubicin—Muscular weakness—Dextrothyroxine—hypothyroidism	0.000595	0.00682	CcSEcCtD
Doxorubicin—Sepsis—Liotrix—hypothyroidism	0.000593	0.0068	CcSEcCtD
Doxorubicin—AKR1A1—adrenal gland—hypothyroidism	0.000593	0.00598	CbGeAlD
Doxorubicin—AKR1A1—blood—hypothyroidism	0.000592	0.00598	CbGeAlD
Doxorubicin—NDUFS3—heart—hypothyroidism	0.000591	0.00596	CbGeAlD
Doxorubicin—CBR3—cerebellum—hypothyroidism	0.000586	0.00591	CbGeAlD
Doxorubicin—Dysphagia—Levothyroxine—hypothyroidism	0.000583	0.00669	CcSEcCtD
Doxorubicin—Dysphagia—Dextrothyroxine—hypothyroidism	0.000583	0.00669	CcSEcCtD
Doxorubicin—DHCR7—adrenal cortex—hypothyroidism	0.00058	0.00585	CbGeAlD
Doxorubicin—Phlebitis—Liotrix—hypothyroidism	0.000576	0.0066	CcSEcCtD
Doxorubicin—AURKA—gonad—hypothyroidism	0.000574	0.0058	CbGeAlD
Doxorubicin—AKR1A1—thyroid gland—hypothyroidism	0.000572	0.00577	CbGeAlD
Doxorubicin—Angina pectoris—Levothyroxine—hypothyroidism	0.000568	0.00651	CcSEcCtD
Doxorubicin—Angina pectoris—Dextrothyroxine—hypothyroidism	0.000568	0.00651	CcSEcCtD
Doxorubicin—NOS1—cardiovascular system—hypothyroidism	0.000568	0.00573	CbGeAlD
Doxorubicin—NDUFS2—cardiovascular system—hypothyroidism	0.000564	0.00569	CbGeAlD
Doxorubicin—DHCR7—heart—hypothyroidism	0.000561	0.00566	CbGeAlD
Doxorubicin—AURKA—pituitary gland—hypothyroidism	0.00056	0.00566	CbGeAlD
Doxorubicin—NDUFS3—cardiovascular system—hypothyroidism	0.000557	0.00562	CbGeAlD
Doxorubicin—AKR1A1—female gonad—hypothyroidism	0.000553	0.00558	CbGeAlD
Doxorubicin—Cardiac failure congestive—Liotrix—hypothyroidism	0.000547	0.00627	CcSEcCtD
Doxorubicin—NDUFS7—adrenal gland—hypothyroidism	0.000539	0.00543	CbGeAlD
Doxorubicin—NDUFS7—blood—hypothyroidism	0.000538	0.00543	CbGeAlD
Doxorubicin—Renal failure acute—Liotrix—hypothyroidism	0.000538	0.00616	CcSEcCtD
Doxorubicin—Body temperature increased—Liothyronine—hypothyroidism	0.000534	0.00612	CcSEcCtD
Doxorubicin—YWHAG—adrenal cortex—hypothyroidism	0.000532	0.00537	CbGeAlD
Doxorubicin—Increased appetite—Liotrix—hypothyroidism	0.000528	0.00606	CcSEcCtD
Doxorubicin—Weight decreased—Dextrothyroxine—hypothyroidism	0.000528	0.00605	CcSEcCtD
Doxorubicin—Weight decreased—Levothyroxine—hypothyroidism	0.000528	0.00605	CcSEcCtD
Doxorubicin—Renal impairment—Liotrix—hypothyroidism	0.000522	0.00598	CcSEcCtD
Doxorubicin—NDUFS7—thyroid gland—hypothyroidism	0.00052	0.00524	CbGeAlD
Doxorubicin—ABCC6—cardiovascular system—hypothyroidism	0.000516	0.00521	CbGeAlD
Doxorubicin—NOS1—gonad—hypothyroidism	0.000515	0.0052	CbGeAlD
Doxorubicin—YWHAG—heart—hypothyroidism	0.000515	0.0052	CbGeAlD
Doxorubicin—NDUFS2—gonad—hypothyroidism	0.000512	0.00517	CbGeAlD
Doxorubicin—Cardiac failure—Liotrix—hypothyroidism	0.000509	0.00583	CcSEcCtD
Doxorubicin—Hypoglycaemia—Liotrix—hypothyroidism	0.000509	0.00583	CcSEcCtD
Doxorubicin—Cerebrovascular accident—Liotrix—hypothyroidism	0.000507	0.00581	CcSEcCtD
Doxorubicin—NDUFS3—gonad—hypothyroidism	0.000506	0.0051	CbGeAlD
Doxorubicin—NDUFS7—female gonad—hypothyroidism	0.000502	0.00507	CbGeAlD
Doxorubicin—AURKA—adrenal gland—hypothyroidism	0.000501	0.00505	CbGeAlD
Doxorubicin—AURKA—blood—hypothyroidism	0.000501	0.00505	CbGeAlD
Doxorubicin—NDUFS2—pituitary gland—hypothyroidism	0.0005	0.00504	CbGeAlD
Doxorubicin—Sweating—Dextrothyroxine—hypothyroidism	0.000499	0.00571	CcSEcCtD
Doxorubicin—Sweating—Levothyroxine—hypothyroidism	0.000499	0.00571	CcSEcCtD
Doxorubicin—CYP3A4—urine—hypothyroidism	0.000495	0.00499	CbGeAlD
Doxorubicin—NDUFS3—pituitary gland—hypothyroidism	0.000493	0.00498	CbGeAlD
Doxorubicin—AKR1A1—testis—hypothyroidism	0.00049	0.00494	CbGeAlD
Doxorubicin—Affect lability—Liotrix—hypothyroidism	0.000489	0.0056	CcSEcCtD
Doxorubicin—CYP2D6—urine—hypothyroidism	0.000487	0.00491	CbGeAlD
Doxorubicin—YWHAG—cardiovascular system—hypothyroidism	0.000486	0.0049	CbGeAlD
Doxorubicin—AURKA—thyroid gland—hypothyroidism	0.000483	0.00488	CbGeAlD
Doxorubicin—RALBP1—adrenal cortex—hypothyroidism	0.000481	0.00485	CbGeAlD
Doxorubicin—DHCR7—gonad—hypothyroidism	0.000481	0.00485	CbGeAlD
Doxorubicin—Cardiac arrest—Liotrix—hypothyroidism	0.000472	0.00541	CcSEcCtD
Doxorubicin—Mood swings—Liotrix—hypothyroidism	0.00047	0.00539	CcSEcCtD
Doxorubicin—DHCR7—pituitary gland—hypothyroidism	0.000469	0.00473	CbGeAlD
Doxorubicin—AURKA—female gonad—hypothyroidism	0.000467	0.00471	CbGeAlD
Doxorubicin—Blood creatinine increased—Liotrix—hypothyroidism	0.000465	0.00533	CcSEcCtD
Doxorubicin—RALBP1—heart—hypothyroidism	0.000465	0.00469	CbGeAlD
Doxorubicin—AKR1A1—liver—hypothyroidism	0.000463	0.00467	CbGeAlD
Doxorubicin—Dehydration—Liotrix—hypothyroidism	0.000462	0.00529	CcSEcCtD
Doxorubicin—NOS3—heart—hypothyroidism	0.000457	0.00462	CbGeAlD
Doxorubicin—AKR1A1—cerebellum—hypothyroidism	0.000453	0.00457	CbGeAlD
Doxorubicin—Hypokalaemia—Liotrix—hypothyroidism	0.000452	0.00518	CcSEcCtD
Doxorubicin—NOS1—blood—hypothyroidism	0.000449	0.00453	CbGeAlD
Doxorubicin—CBR1—adrenal cortex—hypothyroidism	0.000449	0.00453	CbGeAlD
Doxorubicin—NDUFS2—adrenal gland—hypothyroidism	0.000446	0.0045	CbGeAlD
Doxorubicin—NDUFS2—blood—hypothyroidism	0.000446	0.0045	CbGeAlD
Doxorubicin—NDUFS7—testis—hypothyroidism	0.000445	0.00449	CbGeAlD
Doxorubicin—AKR1C3—adrenal cortex—hypothyroidism	0.000443	0.00447	CbGeAlD
Doxorubicin—YWHAG—gonad—hypothyroidism	0.000441	0.00445	CbGeAlD
Doxorubicin—NDUFS3—adrenal gland—hypothyroidism	0.000441	0.00445	CbGeAlD
Doxorubicin—NDUFS3—blood—hypothyroidism	0.000441	0.00445	CbGeAlD
Doxorubicin—RALBP1—cardiovascular system—hypothyroidism	0.000439	0.00443	CbGeAlD
Doxorubicin—Muscular weakness—Liotrix—hypothyroidism	0.000438	0.00502	CcSEcCtD
Doxorubicin—CBR1—heart—hypothyroidism	0.000434	0.00438	CbGeAlD
Doxorubicin—NOS1—thyroid gland—hypothyroidism	0.000433	0.00437	CbGeAlD
Doxorubicin—Flushing—Dextrothyroxine—hypothyroidism	0.000433	0.00497	CcSEcCtD
Doxorubicin—Flushing—Levothyroxine—hypothyroidism	0.000433	0.00497	CcSEcCtD
Doxorubicin—Abdominal distension—Liotrix—hypothyroidism	0.000432	0.00495	CcSEcCtD
Doxorubicin—NOS3—cardiovascular system—hypothyroidism	0.000432	0.00436	CbGeAlD
Doxorubicin—NDUFS2—thyroid gland—hypothyroidism	0.000431	0.00435	CbGeAlD
Doxorubicin—YWHAG—pituitary gland—hypothyroidism	0.00043	0.00434	CbGeAlD
Doxorubicin—Dysphagia—Liotrix—hypothyroidism	0.000429	0.00492	CcSEcCtD
Doxorubicin—AKR1C3—heart—hypothyroidism	0.000429	0.00433	CbGeAlD
Doxorubicin—NDUFS3—thyroid gland—hypothyroidism	0.000425	0.00429	CbGeAlD
Doxorubicin—NDUFS7—liver—hypothyroidism	0.000421	0.00425	CbGeAlD
Doxorubicin—DHCR7—adrenal gland—hypothyroidism	0.000419	0.00423	CbGeAlD
Doxorubicin—DHCR7—blood—hypothyroidism	0.000419	0.00423	CbGeAlD
Doxorubicin—Angina pectoris—Liotrix—hypothyroidism	0.000418	0.00479	CcSEcCtD
Doxorubicin—Arrhythmia—Dextrothyroxine—hypothyroidism	0.000417	0.00478	CcSEcCtD
Doxorubicin—Arrhythmia—Levothyroxine—hypothyroidism	0.000417	0.00478	CcSEcCtD
Doxorubicin—NDUFS2—female gonad—hypothyroidism	0.000416	0.0042	CbGeAlD
Doxorubicin—AURKA—testis—hypothyroidism	0.000414	0.00418	CbGeAlD
Doxorubicin—Bronchitis—Liotrix—hypothyroidism	0.000413	0.00473	CcSEcCtD
Doxorubicin—Alopecia—Levothyroxine—hypothyroidism	0.000413	0.00473	CcSEcCtD
Doxorubicin—Alopecia—Dextrothyroxine—hypothyroidism	0.000413	0.00473	CcSEcCtD
Doxorubicin—NDUFS7—cerebellum—hypothyroidism	0.000411	0.00415	CbGeAlD
Doxorubicin—NDUFS3—female gonad—hypothyroidism	0.000411	0.00415	CbGeAlD
Doxorubicin—CBR1—cardiovascular system—hypothyroidism	0.00041	0.00413	CbGeAlD
Doxorubicin—ABCC6—blood—hypothyroidism	0.000408	0.00412	CbGeAlD
Doxorubicin—POR—adrenal cortex—hypothyroidism	0.000405	0.00408	CbGeAlD
Doxorubicin—DHCR7—thyroid gland—hypothyroidism	0.000404	0.00408	CbGeAlD
Doxorubicin—Tension—Levothyroxine—hypothyroidism	0.000399	0.00457	CcSEcCtD
Doxorubicin—Tension—Dextrothyroxine—hypothyroidism	0.000399	0.00457	CcSEcCtD
Doxorubicin—Nervousness—Levothyroxine—hypothyroidism	0.000395	0.00452	CcSEcCtD
Doxorubicin—Nervousness—Dextrothyroxine—hypothyroidism	0.000395	0.00452	CcSEcCtD
Doxorubicin—ABCC6—thyroid gland—hypothyroidism	0.000394	0.00397	CbGeAlD
Doxorubicin—POR—heart—hypothyroidism	0.000391	0.00395	CbGeAlD
Doxorubicin—AURKA—liver—hypothyroidism	0.000391	0.00395	CbGeAlD
Doxorubicin—DHCR7—female gonad—hypothyroidism	0.000391	0.00394	CbGeAlD
Doxorubicin—RALBP1—pituitary gland—hypothyroidism	0.000388	0.00392	CbGeAlD
Doxorubicin—Weight decreased—Liotrix—hypothyroidism	0.000388	0.00445	CcSEcCtD
Doxorubicin—YWHAG—adrenal gland—hypothyroidism	0.000384	0.00388	CbGeAlD
Doxorubicin—YWHAG—blood—hypothyroidism	0.000384	0.00388	CbGeAlD
Doxorubicin—Renal failure—Liotrix—hypothyroidism	0.000376	0.00431	CcSEcCtD
Doxorubicin—Agitation—Levothyroxine—hypothyroidism	0.000373	0.00428	CcSEcCtD
Doxorubicin—Agitation—Dextrothyroxine—hypothyroidism	0.000373	0.00428	CcSEcCtD
Doxorubicin—CBR1—gonad—hypothyroidism	0.000372	0.00375	CbGeAlD
Doxorubicin—NOS1—testis—hypothyroidism	0.000371	0.00375	CbGeAlD
Doxorubicin—YWHAG—thyroid gland—hypothyroidism	0.000371	0.00374	CbGeAlD
Doxorubicin—NDUFS2—testis—hypothyroidism	0.000369	0.00372	CbGeAlD
Doxorubicin—Sweating—Liotrix—hypothyroidism	0.000367	0.0042	CcSEcCtD
Doxorubicin—NDUFS3—testis—hypothyroidism	0.000365	0.00368	CbGeAlD
Doxorubicin—CBR1—pituitary gland—hypothyroidism	0.000363	0.00366	CbGeAlD
Doxorubicin—NQO1—adrenal cortex—hypothyroidism	0.00036	0.00363	CbGeAlD
Doxorubicin—Palpitations—Dextrothyroxine—hypothyroidism	0.000359	0.00412	CcSEcCtD
Doxorubicin—Palpitations—Levothyroxine—hypothyroidism	0.000359	0.00412	CcSEcCtD
Doxorubicin—YWHAG—female gonad—hypothyroidism	0.000358	0.00362	CbGeAlD
Doxorubicin—AKR1C3—pituitary gland—hypothyroidism	0.000358	0.00361	CbGeAlD
Doxorubicin—Convulsion—Dextrothyroxine—hypothyroidism	0.000352	0.00404	CcSEcCtD
Doxorubicin—Convulsion—Levothyroxine—hypothyroidism	0.000352	0.00404	CcSEcCtD
Doxorubicin—NDUFS2—liver—hypothyroidism	0.000349	0.00352	CbGeAlD
Doxorubicin—NQO1—heart—hypothyroidism	0.000348	0.00351	CbGeAlD
Doxorubicin—RALBP1—adrenal gland—hypothyroidism	0.000347	0.0035	CbGeAlD
Doxorubicin—RALBP1—blood—hypothyroidism	0.000347	0.0035	CbGeAlD
Doxorubicin—DHCR7—testis—hypothyroidism	0.000346	0.00349	CbGeAlD
Doxorubicin—Arthralgia—Levothyroxine—hypothyroidism	0.000346	0.00397	CcSEcCtD
Doxorubicin—Arthralgia—Dextrothyroxine—hypothyroidism	0.000346	0.00397	CcSEcCtD
Doxorubicin—Anxiety—Dextrothyroxine—hypothyroidism	0.000345	0.00395	CcSEcCtD
Doxorubicin—Anxiety—Levothyroxine—hypothyroidism	0.000345	0.00395	CcSEcCtD
Doxorubicin—NDUFS3—liver—hypothyroidism	0.000345	0.00348	CbGeAlD
Doxorubicin—NOS1—cerebellum—hypothyroidism	0.000343	0.00346	CbGeAlD
Doxorubicin—Hypoaesthesia—Liotrix—hypothyroidism	0.000342	0.00392	CcSEcCtD
Doxorubicin—NOS3—adrenal gland—hypothyroidism	0.000341	0.00345	CbGeAlD
Doxorubicin—NOS3—blood—hypothyroidism	0.000341	0.00344	CbGeAlD
Doxorubicin—NDUFS2—cerebellum—hypothyroidism	0.000341	0.00344	CbGeAlD
Doxorubicin—NDUFS3—cerebellum—hypothyroidism	0.000337	0.0034	CbGeAlD
Doxorubicin—RALBP1—thyroid gland—hypothyroidism	0.000335	0.00338	CbGeAlD
Doxorubicin—Confusional state—Levothyroxine—hypothyroidism	0.000334	0.00383	CcSEcCtD
Doxorubicin—Confusional state—Dextrothyroxine—hypothyroidism	0.000334	0.00383	CcSEcCtD
Doxorubicin—NOS3—thyroid gland—hypothyroidism	0.000329	0.00332	CbGeAlD
Doxorubicin—NQO1—cardiovascular system—hypothyroidism	0.000328	0.00331	CbGeAlD
Doxorubicin—DHCR7—liver—hypothyroidism	0.000327	0.0033	CbGeAlD
Doxorubicin—POR—pituitary gland—hypothyroidism	0.000327	0.0033	CbGeAlD
Doxorubicin—Shock—Dextrothyroxine—hypothyroidism	0.000326	0.00374	CcSEcCtD
Doxorubicin—Shock—Levothyroxine—hypothyroidism	0.000326	0.00374	CcSEcCtD
Doxorubicin—CBR1—adrenal gland—hypothyroidism	0.000324	0.00327	CbGeAlD
Doxorubicin—CBR1—blood—hypothyroidism	0.000324	0.00327	CbGeAlD
Doxorubicin—Tachycardia—Dextrothyroxine—hypothyroidism	0.000324	0.00371	CcSEcCtD
Doxorubicin—Tachycardia—Levothyroxine—hypothyroidism	0.000324	0.00371	CcSEcCtD
Doxorubicin—RALBP1—female gonad—hypothyroidism	0.000324	0.00327	CbGeAlD
Doxorubicin—ABCC3—adrenal cortex—hypothyroidism	0.000323	0.00326	CbGeAlD
Doxorubicin—ABCC10—adrenal cortex—hypothyroidism	0.000321	0.00324	CbGeAlD
Doxorubicin—Hyperhidrosis—Levothyroxine—hypothyroidism	0.000321	0.00368	CcSEcCtD
Doxorubicin—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.000321	0.00368	CcSEcCtD
Doxorubicin—AKR1C3—adrenal gland—hypothyroidism	0.00032	0.00323	CbGeAlD
Doxorubicin—AKR1C3—blood—hypothyroidism	0.00032	0.00323	CbGeAlD
Doxorubicin—DHCR7—cerebellum—hypothyroidism	0.00032	0.00323	CbGeAlD
Doxorubicin—ABCC6—liver—hypothyroidism	0.000319	0.00322	CbGeAlD
Doxorubicin—Flushing—Liotrix—hypothyroidism	0.000319	0.00365	CcSEcCtD
Doxorubicin—YWHAG—testis—hypothyroidism	0.000318	0.00321	CbGeAlD
Doxorubicin—CBR1—thyroid gland—hypothyroidism	0.000313	0.00315	CbGeAlD
Doxorubicin—ABCC10—heart—hypothyroidism	0.000311	0.00313	CbGeAlD
Doxorubicin—AKR1C3—thyroid gland—hypothyroidism	0.000309	0.00312	CbGeAlD
Doxorubicin—Arrhythmia—Liotrix—hypothyroidism	0.000307	0.00352	CcSEcCtD
Doxorubicin—Alopecia—Liotrix—hypothyroidism	0.000303	0.00348	CcSEcCtD
Doxorubicin—ABCB11—testis—hypothyroidism	0.000303	0.00305	CbGeAlD
Doxorubicin—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.000302	0.00346	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.000302	0.00346	CcSEcCtD
Doxorubicin—CBR1—female gonad—hypothyroidism	0.000302	0.00305	CbGeAlD
Doxorubicin—YWHAG—liver—hypothyroidism	0.0003	0.00303	CbGeAlD
Doxorubicin—Insomnia—Levothyroxine—hypothyroidism	0.0003	0.00344	CcSEcCtD
Doxorubicin—Insomnia—Dextrothyroxine—hypothyroidism	0.0003	0.00344	CcSEcCtD
Doxorubicin—AKR1C3—female gonad—hypothyroidism	0.000298	0.00301	CbGeAlD
Doxorubicin—Dyspnoea—Levothyroxine—hypothyroidism	0.000296	0.00339	CcSEcCtD
Doxorubicin—Dyspnoea—Dextrothyroxine—hypothyroidism	0.000296	0.00339	CcSEcCtD
Doxorubicin—Flatulence—Liotrix—hypothyroidism	0.000295	0.00338	CcSEcCtD
Doxorubicin—YWHAG—cerebellum—hypothyroidism	0.000294	0.00296	CbGeAlD
Doxorubicin—Tension—Liotrix—hypothyroidism	0.000293	0.00336	CcSEcCtD
Doxorubicin—XDH—liver—hypothyroidism	0.000293	0.00296	CbGeAlD
Doxorubicin—Dysgeusia—Liotrix—hypothyroidism	0.000293	0.00336	CcSEcCtD
Doxorubicin—POR—adrenal gland—hypothyroidism	0.000292	0.00295	CbGeAlD
Doxorubicin—POR—blood—hypothyroidism	0.000292	0.00295	CbGeAlD
Doxorubicin—NQO1—pituitary gland—hypothyroidism	0.000291	0.00293	CbGeAlD
Doxorubicin—Nervousness—Liotrix—hypothyroidism	0.00029	0.00333	CcSEcCtD
Doxorubicin—RALBP1—testis—hypothyroidism	0.000287	0.0029	CbGeAlD
Doxorubicin—ABCB11—liver—hypothyroidism	0.000286	0.00289	CbGeAlD
Doxorubicin—Fatigue—Dextrothyroxine—hypothyroidism	0.000286	0.00328	CcSEcCtD
Doxorubicin—Fatigue—Levothyroxine—hypothyroidism	0.000286	0.00328	CcSEcCtD
Doxorubicin—NOS3—testis—hypothyroidism	0.000282	0.00285	CbGeAlD
Doxorubicin—POR—thyroid gland—hypothyroidism	0.000282	0.00284	CbGeAlD
Doxorubicin—Vision blurred—Liotrix—hypothyroidism	0.000282	0.00323	CcSEcCtD
Doxorubicin—Agitation—Liotrix—hypothyroidism	0.000275	0.00315	CcSEcCtD
Doxorubicin—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.000273	0.00313	CcSEcCtD
Doxorubicin—Feeling abnormal—Levothyroxine—hypothyroidism	0.000273	0.00313	CcSEcCtD
Doxorubicin—POR—female gonad—hypothyroidism	0.000272	0.00275	CbGeAlD
Doxorubicin—TOP2A—adrenal gland—hypothyroidism	0.000272	0.00275	CbGeAlD
Doxorubicin—TOP2A—blood—hypothyroidism	0.000272	0.00275	CbGeAlD
Doxorubicin—RALBP1—liver—hypothyroidism	0.000271	0.00274	CbGeAlD
Doxorubicin—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.000271	0.00311	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.000271	0.00311	CcSEcCtD
Doxorubicin—Syncope—Liotrix—hypothyroidism	0.000268	0.00307	CcSEcCtD
Doxorubicin—CBR1—testis—hypothyroidism	0.000268	0.0027	CbGeAlD
Doxorubicin—NOS3—liver—hypothyroidism	0.000267	0.00269	CbGeAlD
Doxorubicin—ABCC10—gonad—hypothyroidism	0.000266	0.00268	CbGeAlD
Doxorubicin—RALBP1—cerebellum—hypothyroidism	0.000265	0.00267	CbGeAlD
Doxorubicin—AKR1C3—testis—hypothyroidism	0.000265	0.00267	CbGeAlD
Doxorubicin—Palpitations—Liotrix—hypothyroidism	0.000264	0.00303	CcSEcCtD
Doxorubicin—Urticaria—Levothyroxine—hypothyroidism	0.000264	0.00302	CcSEcCtD
Doxorubicin—Urticaria—Dextrothyroxine—hypothyroidism	0.000264	0.00302	CcSEcCtD
Doxorubicin—TOP2A—thyroid gland—hypothyroidism	0.000263	0.00265	CbGeAlD
Doxorubicin—Loss of consciousness—Liotrix—hypothyroidism	0.000263	0.00301	CcSEcCtD
Doxorubicin—Abdominal pain—Dextrothyroxine—hypothyroidism	0.000262	0.00301	CcSEcCtD
Doxorubicin—Body temperature increased—Dextrothyroxine—hypothyroidism	0.000262	0.00301	CcSEcCtD
Doxorubicin—Abdominal pain—Levothyroxine—hypothyroidism	0.000262	0.00301	CcSEcCtD
Doxorubicin—Body temperature increased—Levothyroxine—hypothyroidism	0.000262	0.00301	CcSEcCtD
Doxorubicin—NQO1—adrenal gland—hypothyroidism	0.00026	0.00262	CbGeAlD
Doxorubicin—ABCC10—pituitary gland—hypothyroidism	0.00026	0.00262	CbGeAlD
Doxorubicin—Convulsion—Liotrix—hypothyroidism	0.000259	0.00297	CcSEcCtD
Doxorubicin—Hypertension—Liotrix—hypothyroidism	0.000258	0.00296	CcSEcCtD
Doxorubicin—Chest pain—Liotrix—hypothyroidism	0.000255	0.00292	CcSEcCtD
Doxorubicin—Arthralgia—Liotrix—hypothyroidism	0.000255	0.00292	CcSEcCtD
Doxorubicin—TOP2A—female gonad—hypothyroidism	0.000254	0.00256	CbGeAlD
Doxorubicin—Anxiety—Liotrix—hypothyroidism	0.000254	0.00291	CcSEcCtD
Doxorubicin—CBR1—liver—hypothyroidism	0.000253	0.00256	CbGeAlD
Doxorubicin—NQO1—thyroid gland—hypothyroidism	0.00025	0.00253	CbGeAlD
Doxorubicin—AKR1C3—liver—hypothyroidism	0.00025	0.00252	CbGeAlD
Doxorubicin—CBR1—cerebellum—hypothyroidism	0.000247	0.0025	CbGeAlD
Doxorubicin—Confusional state—Liotrix—hypothyroidism	0.000246	0.00282	CcSEcCtD
Doxorubicin—AKR1C3—cerebellum—hypothyroidism	0.000244	0.00247	CbGeAlD
Doxorubicin—CYP1B1—heart—hypothyroidism	0.000244	0.00246	CbGeAlD
Doxorubicin—Anaphylactic shock—Liotrix—hypothyroidism	0.000244	0.0028	CcSEcCtD
Doxorubicin—Oedema—Liotrix—hypothyroidism	0.000244	0.0028	CcSEcCtD
Doxorubicin—Infection—Liotrix—hypothyroidism	0.000242	0.00278	CcSEcCtD
Doxorubicin—NQO1—female gonad—hypothyroidism	0.000242	0.00244	CbGeAlD
Doxorubicin—POR—testis—hypothyroidism	0.000242	0.00244	CbGeAlD
Doxorubicin—Shock—Liotrix—hypothyroidism	0.00024	0.00275	CcSEcCtD
Doxorubicin—Tachycardia—Liotrix—hypothyroidism	0.000238	0.00273	CcSEcCtD
Doxorubicin—Asthenia—Levothyroxine—hypothyroidism	0.000238	0.00273	CcSEcCtD
Doxorubicin—Asthenia—Dextrothyroxine—hypothyroidism	0.000238	0.00273	CcSEcCtD
Doxorubicin—ABCC10—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000237	0.00378	CbGpPWpGaD
Doxorubicin—RALBP1—EGF/EGFR Signaling Pathway—VAV3—hypothyroidism	0.000236	0.00377	CbGpPWpGaD
Doxorubicin—Hyperhidrosis—Liotrix—hypothyroidism	0.000236	0.0027	CcSEcCtD
Doxorubicin—Pruritus—Dextrothyroxine—hypothyroidism	0.000235	0.00269	CcSEcCtD
Doxorubicin—Pruritus—Levothyroxine—hypothyroidism	0.000235	0.00269	CcSEcCtD
Doxorubicin—ABCC3—adrenal gland—hypothyroidism	0.000233	0.00235	CbGeAlD
Doxorubicin—ABCC3—blood—hypothyroidism	0.000233	0.00235	CbGeAlD
Doxorubicin—Anorexia—Liotrix—hypothyroidism	0.000233	0.00267	CcSEcCtD
Doxorubicin—ABCC10—adrenal gland—hypothyroidism	0.000232	0.00234	CbGeAlD
Doxorubicin—ABCC10—blood—hypothyroidism	0.000232	0.00234	CbGeAlD
Doxorubicin—ABCB8—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000231	0.00369	CbGpPWpGaD
Doxorubicin—CYP1B1—cardiovascular system—hypothyroidism	0.00023	0.00233	CbGeAlD
Doxorubicin—POR—liver—hypothyroidism	0.000228	0.00231	CbGeAlD
Doxorubicin—Hypotension—Liotrix—hypothyroidism	0.000228	0.00261	CcSEcCtD
Doxorubicin—ABCC1—adrenal cortex—hypothyroidism	0.000227	0.00229	CbGeAlD
Doxorubicin—Diarrhoea—Levothyroxine—hypothyroidism	0.000227	0.0026	CcSEcCtD
Doxorubicin—Diarrhoea—Dextrothyroxine—hypothyroidism	0.000227	0.0026	CcSEcCtD
Doxorubicin—ABCC2—NRF2 pathway—SLC5A7—hypothyroidism	0.000227	0.00362	CbGpPWpGaD
Doxorubicin—TOP2A—testis—hypothyroidism	0.000225	0.00227	CbGeAlD
Doxorubicin—ABCC3—thyroid gland—hypothyroidism	0.000225	0.00227	CbGeAlD
Doxorubicin—NDUFS3—Metabolism—IYD—hypothyroidism	0.000224	0.00358	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—IYD—hypothyroidism	0.000224	0.00358	CbGpPWpGaD
Doxorubicin—ABCC6—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000224	0.00358	CbGpPWpGaD
Doxorubicin—ABCC10—thyroid gland—hypothyroidism	0.000224	0.00226	CbGeAlD
Doxorubicin—POR—cerebellum—hypothyroidism	0.000223	0.00225	CbGeAlD
Doxorubicin—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.000222	0.00255	CcSEcCtD
Doxorubicin—SLC22A16—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000221	0.00353	CbGpPWpGaD
Doxorubicin—Insomnia—Liotrix—hypothyroidism	0.000221	0.00253	CcSEcCtD
Doxorubicin—ABCC1—heart—hypothyroidism	0.00022	0.00222	CbGeAlD
Doxorubicin—Paraesthesia—Liotrix—hypothyroidism	0.000219	0.00251	CcSEcCtD
Doxorubicin—Dyspnoea—Liotrix—hypothyroidism	0.000218	0.00249	CcSEcCtD
Doxorubicin—ABCC3—female gonad—hypothyroidism	0.000217	0.00219	CbGeAlD
Doxorubicin—ABCC10—female gonad—hypothyroidism	0.000216	0.00218	CbGeAlD
Doxorubicin—NQO1—testis—hypothyroidism	0.000215	0.00217	CbGeAlD
Doxorubicin—Decreased appetite—Liotrix—hypothyroidism	0.000212	0.00243	CcSEcCtD
Doxorubicin—NDUFS2—Metabolism—IYD—hypothyroidism	0.000211	0.00337	CbGpPWpGaD
Doxorubicin—Vomiting—Levothyroxine—hypothyroidism	0.000211	0.00242	CcSEcCtD
Doxorubicin—Vomiting—Dextrothyroxine—hypothyroidism	0.000211	0.00242	CcSEcCtD
Doxorubicin—Fatigue—Liotrix—hypothyroidism	0.00021	0.00241	CcSEcCtD
Doxorubicin—CYP1B1—gonad—hypothyroidism	0.000209	0.00211	CbGeAlD
Doxorubicin—Rash—Dextrothyroxine—hypothyroidism	0.000209	0.0024	CcSEcCtD
Doxorubicin—Rash—Levothyroxine—hypothyroidism	0.000209	0.0024	CcSEcCtD
Doxorubicin—Dermatitis—Dextrothyroxine—hypothyroidism	0.000209	0.00239	CcSEcCtD
Doxorubicin—Dermatitis—Levothyroxine—hypothyroidism	0.000209	0.00239	CcSEcCtD
Doxorubicin—Constipation—Liotrix—hypothyroidism	0.000209	0.00239	CcSEcCtD
Doxorubicin—Headache—Dextrothyroxine—hypothyroidism	0.000208	0.00238	CcSEcCtD
Doxorubicin—Headache—Levothyroxine—hypothyroidism	0.000208	0.00238	CcSEcCtD
Doxorubicin—TOP2A—Circadian rythm related genes—NKX2-1—hypothyroidism	0.000208	0.00332	CbGpPWpGaD
Doxorubicin—NOS3—Plasma membrane estrogen receptor signaling—IGF1—hypothyroidism	0.000204	0.00326	CbGpPWpGaD
Doxorubicin—CYP1B1—pituitary gland—hypothyroidism	0.000204	0.00206	CbGeAlD
Doxorubicin—NQO1—liver—hypothyroidism	0.000203	0.00205	CbGeAlD
Doxorubicin—Feeling abnormal—Liotrix—hypothyroidism	0.000201	0.0023	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Liotrix—hypothyroidism	0.0002	0.00229	CcSEcCtD
Doxorubicin—CYP1B1—Endogenous sterols—POMC—hypothyroidism	0.000199	0.00317	CbGpPWpGaD
Doxorubicin—NQO1—cerebellum—hypothyroidism	0.000198	0.002	CbGeAlD
Doxorubicin—Nausea—Levothyroxine—hypothyroidism	0.000197	0.00226	CcSEcCtD
Doxorubicin—Nausea—Dextrothyroxine—hypothyroidism	0.000197	0.00226	CcSEcCtD
Doxorubicin—NQO1—Amino acid and derivative metabolism—TSHB—hypothyroidism	0.000197	0.00314	CbGpPWpGaD
Doxorubicin—ABCC10—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000196	0.00313	CbGpPWpGaD
Doxorubicin—Urticaria—Liotrix—hypothyroidism	0.000194	0.00222	CcSEcCtD
Doxorubicin—Abdominal pain—Liotrix—hypothyroidism	0.000193	0.00221	CcSEcCtD
Doxorubicin—Body temperature increased—Liotrix—hypothyroidism	0.000193	0.00221	CcSEcCtD
Doxorubicin—ABCC3—testis—hypothyroidism	0.000193	0.00194	CbGeAlD
Doxorubicin—ABCC10—testis—hypothyroidism	0.000192	0.00193	CbGeAlD
Doxorubicin—NDUFS3—Metabolism—ATP5O—hypothyroidism	0.000191	0.00304	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—ATP5O—hypothyroidism	0.000191	0.00304	CbGpPWpGaD
Doxorubicin—ABCG2—adrenal cortex—hypothyroidism	0.000188	0.0019	CbGeAlD
Doxorubicin—ABCC2—adrenal gland—hypothyroidism	0.000186	0.00188	CbGeAlD
Doxorubicin—ABCC2—blood—hypothyroidism	0.000186	0.00188	CbGeAlD
Doxorubicin—AURKA—EGF/EGFR Signaling Pathway—VAV3—hypothyroidism	0.000184	0.00293	CbGpPWpGaD
Doxorubicin—ABCC1—pituitary gland—hypothyroidism	0.000184	0.00185	CbGeAlD
Doxorubicin—CYP1B1—adrenal gland—hypothyroidism	0.000182	0.00184	CbGeAlD
Doxorubicin—CYP1B1—blood—hypothyroidism	0.000182	0.00184	CbGeAlD
Doxorubicin—ABCC3—liver—hypothyroidism	0.000182	0.00184	CbGeAlD
Doxorubicin—ABCB8—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000182	0.0029	CbGpPWpGaD
Doxorubicin—ABCG2—heart—hypothyroidism	0.000182	0.00184	CbGeAlD
Doxorubicin—ABCC10—liver—hypothyroidism	0.000181	0.00183	CbGeAlD
Doxorubicin—NQO1—NRF2 pathway—SLC5A5—hypothyroidism	0.00018	0.00288	CbGpPWpGaD
Doxorubicin—Hypersensitivity—Liotrix—hypothyroidism	0.00018	0.00206	CcSEcCtD
Doxorubicin—NDUFS3—Metabolism—TPO—hypothyroidism	0.000179	0.00286	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—TPO—hypothyroidism	0.000179	0.00286	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—IYD—hypothyroidism	0.000179	0.00286	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—ATP5O—hypothyroidism	0.000179	0.00286	CbGpPWpGaD
Doxorubicin—YWHAG—Membrane Trafficking—PIK3C2A—hypothyroidism	0.000178	0.00285	CbGpPWpGaD
Doxorubicin—ABCC10—cerebellum—hypothyroidism	0.000177	0.00179	CbGeAlD
Doxorubicin—CYP1B1—thyroid gland—hypothyroidism	0.000176	0.00178	CbGeAlD
Doxorubicin—Asthenia—Liotrix—hypothyroidism	0.000175	0.00201	CcSEcCtD
Doxorubicin—CYP2B6—adrenal cortex—hypothyroidism	0.000173	0.00175	CbGeAlD
Doxorubicin—Pruritus—Liotrix—hypothyroidism	0.000173	0.00198	CcSEcCtD
Doxorubicin—CYP1B1—female gonad—hypothyroidism	0.00017	0.00172	CbGeAlD
Doxorubicin—NDUFS2—Metabolism—TPO—hypothyroidism	0.000169	0.00269	CbGpPWpGaD
Doxorubicin—CYP2B6—heart—hypothyroidism	0.000168	0.00169	CbGeAlD
Doxorubicin—CBR1—Metabolism—IYD—hypothyroidism	0.000167	0.00267	CbGpPWpGaD
Doxorubicin—Diarrhoea—Liotrix—hypothyroidism	0.000167	0.00191	CcSEcCtD
Doxorubicin—ABCC1—adrenal gland—hypothyroidism	0.000164	0.00165	CbGeAlD
Doxorubicin—ABCC1—blood—hypothyroidism	0.000164	0.00165	CbGeAlD
Doxorubicin—Dizziness—Liotrix—hypothyroidism	0.000161	0.00185	CcSEcCtD
Doxorubicin—CYP2B6—cardiovascular system—hypothyroidism	0.000158	0.0016	CbGeAlD
Doxorubicin—ABCC1—thyroid gland—hypothyroidism	0.000158	0.0016	CbGeAlD
Doxorubicin—Vomiting—Liotrix—hypothyroidism	0.000155	0.00178	CcSEcCtD
Doxorubicin—NOS3—SHP2 signaling—IGF1—hypothyroidism	0.000155	0.00247	CbGpPWpGaD
Doxorubicin—NOS3—VEGFA-VEGFR2 Pathway—VAV3—hypothyroidism	0.000154	0.00246	CbGpPWpGaD
Doxorubicin—ABCC2—testis—hypothyroidism	0.000154	0.00155	CbGeAlD
Doxorubicin—Rash—Liotrix—hypothyroidism	0.000154	0.00176	CcSEcCtD
Doxorubicin—Dermatitis—Liotrix—hypothyroidism	0.000154	0.00176	CcSEcCtD
Doxorubicin—ABCC1—female gonad—hypothyroidism	0.000153	0.00154	CbGeAlD
Doxorubicin—Headache—Liotrix—hypothyroidism	0.000153	0.00175	CcSEcCtD
Doxorubicin—DHCR7—Metabolism—ATP5O—hypothyroidism	0.000152	0.00243	CbGpPWpGaD
Doxorubicin—ABCG2—pituitary gland—hypothyroidism	0.000152	0.00153	CbGeAlD
Doxorubicin—CYP1B1—testis—hypothyroidism	0.000151	0.00152	CbGeAlD
Doxorubicin—NQO1—Amino acid and derivative metabolism—SLC5A5—hypothyroidism	0.000147	0.00235	CbGpPWpGaD
Doxorubicin—ABCC2—liver—hypothyroidism	0.000146	0.00147	CbGeAlD
Doxorubicin—NOS3—Signaling by VEGF—VAV3—hypothyroidism	0.000145	0.00232	CbGpPWpGaD
Doxorubicin—Nausea—Liotrix—hypothyroidism	0.000145	0.00166	CcSEcCtD
Doxorubicin—CYP2B6—gonad—hypothyroidism	0.000144	0.00145	CbGeAlD
Doxorubicin—DHCR7—Metabolism—TPO—hypothyroidism	0.000143	0.00229	CbGpPWpGaD
Doxorubicin—SLC22A16—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000143	0.00228	CbGpPWpGaD
Doxorubicin—CYP1B1—liver—hypothyroidism	0.000143	0.00144	CbGeAlD
Doxorubicin—CBR1—Metabolism—ATP5O—hypothyroidism	0.000142	0.00227	CbGpPWpGaD
Doxorubicin—CYP1B1—cerebellum—hypothyroidism	0.000139	0.0014	CbGeAlD
Doxorubicin—YWHAG—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000138	0.00221	CbGpPWpGaD
Doxorubicin—ABCG2—adrenal gland—hypothyroidism	0.000136	0.00137	CbGeAlD
Doxorubicin—ABCG2—blood—hypothyroidism	0.000136	0.00137	CbGeAlD
Doxorubicin—ABCC1—testis—hypothyroidism	0.000136	0.00137	CbGeAlD
Doxorubicin—CBR1—Metabolism—TPO—hypothyroidism	0.000134	0.00213	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000133	0.00212	CbGpPWpGaD
Doxorubicin—ABCG2—thyroid gland—hypothyroidism	0.000131	0.00132	CbGeAlD
Doxorubicin—ABCC1—liver—hypothyroidism	0.000128	0.00129	CbGeAlD
Doxorubicin—ABCG2—female gonad—hypothyroidism	0.000127	0.00128	CbGeAlD
Doxorubicin—ABCC1—cerebellum—hypothyroidism	0.000125	0.00126	CbGeAlD
Doxorubicin—CYP2B6—adrenal gland—hypothyroidism	0.000125	0.00126	CbGeAlD
Doxorubicin—CYP2B6—blood—hypothyroidism	0.000125	0.00126	CbGeAlD
Doxorubicin—CBR1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000124	0.00198	CbGpPWpGaD
Doxorubicin—NOS2—Circadian rythm related genes—AVP—hypothyroidism	0.000115	0.00184	CbGpPWpGaD
Doxorubicin—ABCC3—NRF2 pathway—SLC5A5—hypothyroidism	0.000114	0.00183	CbGpPWpGaD
Doxorubicin—SLC22A16—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000112	0.00179	CbGpPWpGaD
Doxorubicin—ABCG2—testis—hypothyroidism	0.000112	0.00113	CbGeAlD
Doxorubicin—NOS3—Corticotropin-releasing hormone—POMC—hypothyroidism	0.000111	0.00178	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—SH2B3—hypothyroidism	0.000111	0.00177	CbGpPWpGaD
Doxorubicin—NOS3—EGF/EGFR Signaling Pathway—VAV3—hypothyroidism	0.000111	0.00176	CbGpPWpGaD
Doxorubicin—ABCC6—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000108	0.00173	CbGpPWpGaD
Doxorubicin—ABCG2—liver—hypothyroidism	0.000106	0.00107	CbGeAlD
Doxorubicin—ABCG2—cerebellum—hypothyroidism	0.000104	0.00105	CbGeAlD
Doxorubicin—CYP2B6—testis—hypothyroidism	0.000104	0.00105	CbGeAlD
Doxorubicin—CYP2B6—liver—hypothyroidism	9.79e-05	0.000988	CbGeAlD
Doxorubicin—NQO1—Metabolism—IYD—hypothyroidism	9.77e-05	0.00156	CbGpPWpGaD
Doxorubicin—ABCC10—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	9.46e-05	0.00151	CbGpPWpGaD
Doxorubicin—CYP3A4—blood—hypothyroidism	9.45e-05	0.000954	CbGeAlD
Doxorubicin—AKR1C3—Metabolism—IYD—hypothyroidism	9.42e-05	0.0015	CbGpPWpGaD
Doxorubicin—CYP2D6—blood—hypothyroidism	9.3e-05	0.000939	CbGeAlD
Doxorubicin—ABCB1—adrenal cortex—hypothyroidism	9.27e-05	0.000936	CbGeAlD
Doxorubicin—CYP1B1—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	9.23e-05	0.00147	CbGpPWpGaD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	9.16e-05	0.00146	CbGpPWpGaD
Doxorubicin—ABCC2—NRF2 pathway—SLC5A5—hypothyroidism	9.07e-05	0.00145	CbGpPWpGaD
Doxorubicin—ABCB1—heart—hypothyroidism	8.97e-05	0.000905	CbGeAlD
Doxorubicin—XDH—Metabolism—IYD—hypothyroidism	8.76e-05	0.0014	CbGpPWpGaD
Doxorubicin—CYP2D6—female gonad—hypothyroidism	8.68e-05	0.000876	CbGeAlD
Doxorubicin—ABCC6—Transmembrane transport of small molecules—AVP—hypothyroidism	8.52e-05	0.00136	CbGpPWpGaD
Doxorubicin—ABCB1—cardiovascular system—hypothyroidism	8.46e-05	0.000854	CbGeAlD
Doxorubicin—NOS2—Hemostasis—SH2B3—hypothyroidism	8.34e-05	0.00133	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—TSHB—hypothyroidism	8.3e-05	0.00133	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—TSHB—hypothyroidism	8.3e-05	0.00133	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—ATP5O—hypothyroidism	8.3e-05	0.00133	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—ATP5O—hypothyroidism	8.01e-05	0.00128	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—IYD—hypothyroidism	7.96e-05	0.00127	CbGpPWpGaD
Doxorubicin—TOP2A—Circadian rythm related genes—AVP—hypothyroidism	7.89e-05	0.00126	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—TPO—hypothyroidism	7.81e-05	0.00125	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—TSHB—hypothyroidism	7.81e-05	0.00125	CbGpPWpGaD
Doxorubicin—CYP2D6—testis—hypothyroidism	7.7e-05	0.000777	CbGeAlD
Doxorubicin—ABCB1—gonad—hypothyroidism	7.68e-05	0.000775	CbGeAlD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	7.59e-05	0.00121	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—VAV3—hypothyroidism	7.59e-05	0.00121	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—TPO—hypothyroidism	7.53e-05	0.0012	CbGpPWpGaD
Doxorubicin—ABCB1—pituitary gland—hypothyroidism	7.49e-05	0.000756	CbGeAlD
Doxorubicin—CYP1B1—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	7.49e-05	0.0012	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—ATP5O—hypothyroidism	7.45e-05	0.00119	CbGpPWpGaD
Doxorubicin—ABCC10—Transmembrane transport of small molecules—AVP—hypothyroidism	7.44e-05	0.00119	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—PIK3C2A—hypothyroidism	7.4e-05	0.00118	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—PIK3C2A—hypothyroidism	7.4e-05	0.00118	CbGpPWpGaD
Doxorubicin—CYP3A4—liver—hypothyroidism	7.39e-05	0.000746	CbGeAlD
Doxorubicin—CYP2D6—liver—hypothyroidism	7.28e-05	0.000734	CbGeAlD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	7.26e-05	0.00116	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	7.18e-05	0.00115	CbGpPWpGaD
Doxorubicin—CYP2D6—cerebellum—hypothyroidism	7.11e-05	0.000717	CbGeAlD
Doxorubicin—XDH—Metabolism—TPO—hypothyroidism	7e-05	0.00112	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	6.98e-05	0.00111	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—PIK3C2A—hypothyroidism	6.96e-05	0.00111	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CLTC—hypothyroidism	6.83e-05	0.00109	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—ATP5O—hypothyroidism	6.77e-05	0.00108	CbGpPWpGaD
Doxorubicin—ABCB1—adrenal gland—hypothyroidism	6.69e-05	0.000675	CbGeAlD
Doxorubicin—ABCB1—blood—hypothyroidism	6.69e-05	0.000675	CbGeAlD
Doxorubicin—DHCR7—Metabolism—TSHB—hypothyroidism	6.64e-05	0.00106	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—SH2B3—hypothyroidism	6.48e-05	0.00103	CbGpPWpGaD
Doxorubicin—ABCB1—thyroid gland—hypothyroidism	6.46e-05	0.000652	CbGeAlD
Doxorubicin—ABCB11—Metabolism—IYD—hypothyroidism	6.46e-05	0.00103	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—TPO—hypothyroidism	6.36e-05	0.00102	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	6.32e-05	0.00101	CbGpPWpGaD
Doxorubicin—ABCB1—female gonad—hypothyroidism	6.24e-05	0.00063	CbGeAlD
Doxorubicin—NDUFS3—Metabolism—SLC5A5—hypothyroidism	6.22e-05	0.000992	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—SLC5A5—hypothyroidism	6.22e-05	0.000992	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—TSHB—hypothyroidism	6.19e-05	0.000988	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—IYD—hypothyroidism	6.19e-05	0.000988	CbGpPWpGaD
Doxorubicin—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	6.16e-05	0.000983	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	6.02e-05	0.000961	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	5.95e-05	0.00095	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—PIK3C2A—hypothyroidism	5.92e-05	0.000944	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—TRH—hypothyroidism	5.9e-05	0.000942	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—SLC5A5—hypothyroidism	5.84e-05	0.000933	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	5.84e-05	0.000932	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—VAV3—hypothyroidism	5.72e-05	0.000914	CbGpPWpGaD
Doxorubicin—ABCB1—testis—hypothyroidism	5.54e-05	0.000559	CbGeAlD
Doxorubicin—CBR1—Metabolism—PIK3C2A—hypothyroidism	5.52e-05	0.000881	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—ATP5O—hypothyroidism	5.49e-05	0.000876	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	5.44e-05	0.000869	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—ATP5O—hypothyroidism	5.26e-05	0.00084	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—TSHB—hypothyroidism	5.26e-05	0.00084	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—TSHR—hypothyroidism	5.26e-05	0.00084	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	5.25e-05	0.000839	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	5.23e-05	0.000836	CbGpPWpGaD
Doxorubicin—ABCB1—liver—hypothyroidism	5.23e-05	0.000528	CbGeAlD
Doxorubicin—ABCB11—Metabolism—TPO—hypothyroidism	5.16e-05	0.000824	CbGpPWpGaD
Doxorubicin—ABCB1—cerebellum—hypothyroidism	5.11e-05	0.000516	CbGeAlD
Doxorubicin—CYP2B6—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	4.99e-05	0.000797	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—SLC5A5—hypothyroidism	4.97e-05	0.000793	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—TPO—hypothyroidism	4.95e-05	0.00079	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—IYD—hypothyroidism	4.85e-05	0.000774	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	4.78e-05	0.000763	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—IYD—hypothyroidism	4.69e-05	0.000749	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—SH2B3—hypothyroidism	4.69e-05	0.000749	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—IGF1—hypothyroidism	4.67e-05	0.000746	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—SLC5A5—hypothyroidism	4.63e-05	0.00074	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	4.59e-05	0.000732	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—VAV3—hypothyroidism	4.45e-05	0.00071	CbGpPWpGaD
Doxorubicin—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	4.28e-05	0.000683	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—IYD—hypothyroidism	4.27e-05	0.000681	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—ATP5O—hypothyroidism	4.12e-05	0.000658	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—ATP5O—hypothyroidism	3.99e-05	0.000637	CbGpPWpGaD
Doxorubicin—CYP1B1—Biological oxidations—POMC—hypothyroidism	3.98e-05	0.000635	CbGpPWpGaD
Doxorubicin—NOS1—Disease—PRL—hypothyroidism	3.97e-05	0.000634	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—TPO—hypothyroidism	3.88e-05	0.000619	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CLTC—hypothyroidism	3.78e-05	0.000604	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—TPO—hypothyroidism	3.75e-05	0.000599	CbGpPWpGaD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	3.66e-05	0.000585	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—ATP5O—hypothyroidism	3.63e-05	0.000579	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—TSHB—hypothyroidism	3.61e-05	0.000577	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	3.59e-05	0.000574	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—IGF1—hypothyroidism	3.53e-05	0.000563	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—TSHB—hypothyroidism	3.49e-05	0.000557	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—PRL—hypothyroidism	3.48e-05	0.000555	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	3.48e-05	0.000555	CbGpPWpGaD
Doxorubicin—CYP2D6—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	3.47e-05	0.000554	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	3.42e-05	0.000545	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—TPO—hypothyroidism	3.41e-05	0.000545	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TRH—hypothyroidism	3.27e-05	0.000522	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—POMC—hypothyroidism	3.25e-05	0.000519	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—POMC—hypothyroidism	3.25e-05	0.000519	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—TSHB—hypothyroidism	3.24e-05	0.000517	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—PIK3C2A—hypothyroidism	3.22e-05	0.000514	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—VAV3—hypothyroidism	3.22e-05	0.000514	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CLTC—hypothyroidism	3.2e-05	0.00051	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—IYD—hypothyroidism	3.13e-05	0.000499	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—PIK3C2A—hypothyroidism	3.11e-05	0.000496	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—AVP—hypothyroidism	3.1e-05	0.000495	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	3.07e-05	0.000489	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—POMC—hypothyroidism	3.06e-05	0.000488	CbGpPWpGaD
Doxorubicin—NOS2—Disease—PRL—hypothyroidism	3e-05	0.000478	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—TSHB—hypothyroidism	2.95e-05	0.00047	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TSHB—hypothyroidism	2.92e-05	0.000465	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TSHR—hypothyroidism	2.92e-05	0.000465	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	2.9e-05	0.000463	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—PIK3C2A—hypothyroidism	2.89e-05	0.000461	CbGpPWpGaD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—AVP—hypothyroidism	2.88e-05	0.00046	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	2.87e-05	0.000458	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	2.83e-05	0.000452	CbGpPWpGaD
Doxorubicin—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	2.8e-05	0.000447	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TRH—hypothyroidism	2.76e-05	0.000441	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—PRL—hypothyroidism	2.75e-05	0.000439	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—IGF1—hypothyroidism	2.74e-05	0.000437	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—SLC5A5—hypothyroidism	2.71e-05	0.000432	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ATP5O—hypothyroidism	2.66e-05	0.000425	CbGpPWpGaD
Doxorubicin—CYP2B6—Biological oxidations—POMC—hypothyroidism	2.65e-05	0.000423	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—PIK3C2A—hypothyroidism	2.63e-05	0.000419	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—SLC5A5—hypothyroidism	2.61e-05	0.000417	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—POMC—hypothyroidism	2.6e-05	0.000415	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—SH2B3—hypothyroidism	2.6e-05	0.000415	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	2.52e-05	0.000403	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—TPO—hypothyroidism	2.5e-05	0.000399	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TSHB—hypothyroidism	2.46e-05	0.000393	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TSHR—hypothyroidism	2.46e-05	0.000393	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—SLC5A5—hypothyroidism	2.43e-05	0.000387	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—POMC—hypothyroidism	2.42e-05	0.000387	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—TSHB—hypothyroidism	2.39e-05	0.000381	CbGpPWpGaD
Doxorubicin—NOS3—Disease—PRL—hypothyroidism	2.33e-05	0.000371	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—IYD—hypothyroidism	2.31e-05	0.000368	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—TSHB—hypothyroidism	2.29e-05	0.000366	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—AVP—hypothyroidism	2.29e-05	0.000365	CbGpPWpGaD
Doxorubicin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	2.27e-05	0.000362	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—AVP—hypothyroidism	2.26e-05	0.000361	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—SLC5A5—hypothyroidism	2.21e-05	0.000352	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—SH2B3—hypothyroidism	2.2e-05	0.00035	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—IYD—hypothyroidism	2.17e-05	0.000347	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PIK3C2A—hypothyroidism	2.13e-05	0.00034	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	2.1e-05	0.000335	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—POMC—hypothyroidism	2.06e-05	0.000329	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PIK3C2A—hypothyroidism	2.04e-05	0.000326	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	2.01e-05	0.000322	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—AVP—hypothyroidism	1.99e-05	0.000317	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—IGF1—hypothyroidism	1.98e-05	0.000316	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ATP5O—hypothyroidism	1.96e-05	0.000313	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—PRL—hypothyroidism	1.93e-05	0.000308	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ATP5O—hypothyroidism	1.85e-05	0.000295	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—TPO—hypothyroidism	1.84e-05	0.000294	CbGpPWpGaD
Doxorubicin—CYP2D6—Biological oxidations—POMC—hypothyroidism	1.84e-05	0.000294	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—TSHB—hypothyroidism	1.8e-05	0.000287	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—SLC5A5—hypothyroidism	1.79e-05	0.000286	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—VAV3—hypothyroidism	1.78e-05	0.000285	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—TPO—hypothyroidism	1.74e-05	0.000278	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—TSHB—hypothyroidism	1.74e-05	0.000277	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	1.73e-05	0.000276	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—AVP—hypothyroidism	1.72e-05	0.000274	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—SLC5A5—hypothyroidism	1.72e-05	0.000274	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—PRL—hypothyroidism	1.63e-05	0.00026	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PIK3C2A—hypothyroidism	1.6e-05	0.000255	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—TSHB—hypothyroidism	1.58e-05	0.000252	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.58e-05	0.000252	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PIK3C2A—hypothyroidism	1.55e-05	0.000247	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.53e-05	0.000244	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—VAV3—hypothyroidism	1.51e-05	0.000241	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—AVP—hypothyroidism	1.45e-05	0.000232	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—IYD—hypothyroidism	1.42e-05	0.000227	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PRL—hypothyroidism	1.42e-05	0.000226	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—POMC—hypothyroidism	1.42e-05	0.000226	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PIK3C2A—hypothyroidism	1.41e-05	0.000225	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—POMC—hypothyroidism	1.37e-05	0.000218	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	1.37e-05	0.000218	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—SLC5A5—hypothyroidism	1.34e-05	0.000215	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—SLC5A5—hypothyroidism	1.3e-05	0.000207	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—POMC—hypothyroidism	1.27e-05	0.000203	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ATP5O—hypothyroidism	1.21e-05	0.000193	CbGpPWpGaD
Doxorubicin—CYP3A4—Biological oxidations—POMC—hypothyroidism	1.21e-05	0.000192	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—SLC5A5—hypothyroidism	1.18e-05	0.000189	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—TSHB—hypothyroidism	1.16e-05	0.000185	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—POMC—hypothyroidism	1.15e-05	0.000184	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—POMC—hypothyroidism	1.14e-05	0.000182	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—TPO—hypothyroidism	1.14e-05	0.000181	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—IGF1—hypothyroidism	1.1e-05	0.000175	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—AVP—hypothyroidism	1.07e-05	0.000172	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PIK3C2A—hypothyroidism	1.03e-05	0.000165	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—POMC—hypothyroidism	9.65e-06	0.000154	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—POMC—hypothyroidism	9.36e-06	0.000149	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IGF1—hypothyroidism	9.28e-06	0.000148	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—POMC—hypothyroidism	8.97e-06	0.000143	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—SLC5A5—hypothyroidism	8.67e-06	0.000138	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—TSHB—hypothyroidism	8.54e-06	0.000136	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—TSHB—hypothyroidism	8.05e-06	0.000128	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PIK3C2A—hypothyroidism	7.61e-06	0.000122	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PIK3C2A—hypothyroidism	7.17e-06	0.000115	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—POMC—hypothyroidism	7.03e-06	0.000112	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—POMC—hypothyroidism	6.8e-06	0.000109	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—SLC5A5—hypothyroidism	6.39e-06	0.000102	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—POMC—hypothyroidism	6.19e-06	9.88e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—SLC5A5—hypothyroidism	6.02e-06	9.62e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—TSHB—hypothyroidism	5.26e-06	8.4e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	4.69e-06	7.49e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—POMC—hypothyroidism	4.54e-06	7.24e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—SLC5A5—hypothyroidism	3.94e-06	6.29e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—POMC—hypothyroidism	3.35e-06	5.34e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—POMC—hypothyroidism	3.15e-06	5.03e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—POMC—hypothyroidism	2.06e-06	3.29e-05	CbGpPWpGaD
